Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug conjugate-based anticancer therapy - Current status and perspectives.
Yang Y, Wang S, Ma P, Jiang Y, Cheng K, Yu Y, Jiang N, Miao H, Tang Q, Liu F, Zha Y, Li N. Yang Y, et al. Among authors: tang q. Cancer Lett. 2023 Jan 1;552:215969. doi: 10.1016/j.canlet.2022.215969. Epub 2022 Oct 22. Cancer Lett. 2023. PMID: 36279982 Free article. Review.
Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours.
Wang S, Huang HY, Wu D, Fang H, Ying J, Bai Y, Yu Y, Fang Y, Jiang N, Sun C, Yu A, Fan Q, Xing S, Ni Y, Zhang W, Wu C, Ji X, Wang H, Guo Y, Tang Q, Wang Y, Tang Y, Li N. Wang S, et al. Among authors: tang y, tang q. BMJ Open. 2021 Jun 3;11(6):e044543. doi: 10.1136/bmjopen-2020-044543. BMJ Open. 2021. PMID: 34083331 Free PMC article.
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials.
Wang S, Yang Y, Ma P, Huang H, Tang Q, Miao H, Fang Y, Jiang N, Li Y, Zhu Q, Tao W, Zha Y, Li N. Wang S, et al. Among authors: tang q. Mol Ther Oncolytics. 2022 Feb 22;24:799-813. doi: 10.1016/j.omto.2022.02.019. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2022. PMID: 35317518 Free PMC article. Review.
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients.
Wang S, Li Q, Ma P, Fang Y, Yu Y, Jiang N, Miao H, Tang Q, Yang Y, Xing S, Chen R, Yi X, Li N. Wang S, et al. Among authors: tang q. Front Mol Biosci. 2022 Mar 11;9:831382. doi: 10.3389/fmolb.2022.831382. eCollection 2022. Front Mol Biosci. 2022. PMID: 35359599 Free PMC article.
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges.
Huang H, Tang Y, Yu Y, Yu A, Wu D, Fang H, Wang S, Sun C, Wang X, Fan Q, Fang Y, Tang Q, Jiang N, Du J, Miao H, Bai Y, Ma P, Xing S, Cui D, Miao S, Jiang Y, Zhu J, Zhu Q, Leng Y, Guo LW, Liao S, Shao Y, Song Y, Liu Z, Hong M, Luo S, Xu B, Lan G, Li N. Huang H, et al. Among authors: tang y, tang q. Lancet Reg Health West Pac. 2022 Nov 18;31:100624. doi: 10.1016/j.lanwpc.2022.100624. eCollection 2023 Feb. Lancet Reg Health West Pac. 2022. PMID: 36426285 Free PMC article. Review.
Targeting rare tumors: new focus for clinical research in China.
Wang S, Jiang Y, Miao H, Fang Y, Jiang N, Yu Y, Ma P, Tang Q, Cui D, Fang H, Huang H, Fan Q, Sun C, Yu A, Miao S, Du J, Zhu J, Wang Y, Li N. Wang S, et al. Among authors: tang q. EMBO Mol Med. 2023 Jan 11;15(1):e16415. doi: 10.15252/emmm.202216415. Epub 2022 Nov 28. EMBO Mol Med. 2023. PMID: 36437781 Free PMC article.
Rare tumors: a blue ocean of investigation.
Wang S, Ma P, Jiang N, Jiang Y, Yu Y, Fang Y, Miao H, Huang H, Tang Q, Cui D, Fang H, Zhang H, Fan Q, Wang Y, Liu G, Yu Z, Lei Q, Li N. Wang S, et al. Among authors: tang q. Front Med. 2023 Apr;17(2):220-230. doi: 10.1007/s11684-023-0984-z. Epub 2023 Apr 26. Front Med. 2023. PMID: 37185946 Review.
7,145 results